![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/46 | |
A61K 35/76 | |||
A61P 35/00 | |||
C07K 14/14 | |||
C12N 15/86 | |||
C12N 7/01 |
(11) | Number of the document | 2132315 |
(13) | Kind of document | T |
(96) | European patent application number | 08733587.3 |
Date of filing the European patent application | 2008-03-11 | |
(97) | Date of publication of the European application | 2009-12-16 |
(45) | Date of publication and mention of the grant of the patent | 2015-07-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2008/000483 |
Date | 2008-03-11 |
(87) | Number | WO 2008/110004 |
Date | 2008-09-18 |
(30) | Number | Date | Country code |
894425 P | 2007-03-12 | US | |
989568 P | 2007-11-21 | US |
(72) |
COFFEY, Matthew C., CA
|
(73) |
Oncolytics Biotech Inc.,
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7,
CA
|
(54) | REOVIRUSES HAVING MODIFIED SEQUENCES |
REOVIRUSES HAVING MODIFIED SEQUENCES |